Sawai Can Set Itself Apart from Competitors in Post-80% Generic Era through Development Strategy: President

September 25, 2020
Sawai Pharmaceutical President Kenzo Sawai expressed confidence in his company’s business in the “post-80% generic” era, saying that there are many drugs that will go off-patent and that the generic major will be able to distinguish itself from competitors through...read more